ACRS vs GWW · rev $3.6M vs P/E 27, rev $9.76B
Aclaris Therapeutics Inc (ACRS) versus WW Grainger Inc (GWW) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
ACRS currently screens at market cap $615.9M. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Not investment advice. Open the ACRS and GWW stock pages for the full models.
Not investment advice.